mTORC1 inhibition by sirolimus as adjunctive treatment in experimental pneumococcal meningitis. [PDF]
Koning R +5 more
europepmc +1 more source
Optimal dosing for vascular anomalies pediatric patients with population pharmacokinetic model of sirolimus [PDF]
Seongmee Jeong +10 more
openalex +1 more source
Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma [PDF]
Norman M. Kneteman +12 more
openalex +1 more source
A Placebo-Controlled Exploratory Trial of Sirolimus for Tocilizumab-Resistant Idiopathic Multicentric Castleman Disease: Early Termination and Long-Term Extension Results Based on Descriptive Results From Two Patients. [PDF]
Koga T +8 more
europepmc +1 more source
Eosinophilic Fasciitis Triggered by Nivolumab: A Remarkable Efficacy of the mTOR Inhibitor Sirolimus [PDF]
Erwan Le Tallec +9 more
openalex +1 more source
Paclitaxel- and Sirolimus-Coated Balloons Versus Drug-Eluting Stents in Coronary Artery Disease: A Comprehensive Narrative Review. [PDF]
Gherasie FA +4 more
europepmc +1 more source
Improved health-related quality of life in patients treated with topical sirolimus for facial angiofibroma associated with tuberous sclerosis complex [PDF]
Takashi Hatano +6 more
openalex +1 more source
PI3K/AKT/mTOR axis in vascular malformations: from molecular insights to targeted clinical trials. [PDF]
Zheng YY, Hua C, Lin XX.
europepmc +1 more source

